Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Uremic Encephalopathy

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Uremic Encephalopathy

Claudia G. Olano et al.
Free Books & Documents

Excerpt

Uremic encephalopathy is defined as cerebral dysfunction caused by the accumulation of toxins due to acute or chronic renal failure. This condition typically develops in patients with acute or chronic renal failure whose estimated glomerular filtration rate (eGFR) is below 15 mL/min. The clinical presentation of uremic encephalopathy is broad, varying from subtle to florid, and the clinical course is always progressive when left untreated. Uremic encephalopathy is at least partially reversible with the initiation of renal replacement therapy, making it a clear indication to start such treatment.

The syndrome likely results from alterations in hormonal metabolism, retention of uremic solutes, changes in electrolyte and acid-base homeostasis, blood-brain barrier transport, changes in vascular reactivity, and inflammation. Diagnosis of uremic encephalopathy is challenging, as there are no specific clinical, laboratory, or imaging findings. The condition is often diagnosed retrospectively when symptoms improve after dialysis or kidney transplantation. If symptoms do not improve after clearing toxic solutes, other potential causes should be investigated.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Claudia Olano declares no relevant financial relationships with ineligible companies.

Disclosure: Sami Akram declares no relevant financial relationships with ineligible companies.

Disclosure: Muhammad Hashmi declares no relevant financial relationships with ineligible companies.

Disclosure: Harshil Bhatt declares no relevant financial relationships with ineligible companies.

References

    1. Meyer TW, Hostetter TH. Uremia. N Engl J Med. 2007 Sep 27;357(13):1316-25. - PubMed
    1. Biasioli S, D'Andrea G, Feriani M, Chiaramonte S, Fabris A, Ronco C, La Greca G. Uremic encephalopathy: an updating. Clin Nephrol. 1986 Feb;25(2):57-63. - PubMed
    1. Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol. 2011 Apr;31(2):139-43. - PubMed
    1. Rosner MH, Husain-Syed F, Reis T, Ronco C, Vanholder R. Uremic encephalopathy. Kidney Int. 2022 Feb;101(2):227-241. - PubMed
    1. Betjes MG. Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses. Toxins (Basel) 2020 Apr 03;12(4) - PMC - PubMed

Publication types

LinkOut - more resources